Android app Apple app link

Sabra Health Care REIT, Inc. (SBRA) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$20.26
Day's range
$20.75

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
08/31/2026 Barclays Richard Hightower $23.00 $20.61   11.6%
07/22/2026 Robert W. Baird Wesley Golladay $23.00 $22.04   4.36%
05/13/2026 UBS Michael Goldsmith $22.00 $20.97   4.91%
05/11/2026 Cantor Fitzgerald Richard Anderson $22.00 $20.75   6.02%
02/19/2026 UBS Michael Goldsmith $21.00 $20.24   3.78%
02/17/2026 Cantor Fitzgerald Richard Anderson $21.00 $20.17   4.12%
01/20/2026 Truist Financial Michael Lewis $21.00 $19.24   9.15%
12/15/2025 Jefferies Joe Dickstein $22.00 $19.20   14.58%
10/01/2025 Cantor Fitzgerald Richard Anderson $20.00 $18.64   7.3%
09/12/2024 Citigroup Nicholas Joseph $20.00 $18.35   8.99%
09/03/2024 Truist Financial Michael Lewis $18.00 $17.00   5.88%
06/21/2024 Robert W. Baird David Rodgers $16.00 $14.55   9.97%
05/15/2024 Scotiabank Nicholas Yulico $15.00 $14.67   2.25%
05/31/2023 Credit Suisse Omotayo Okusanya $13.00 $10.68   21.72%
12/26/2021 Truist Financial Michael R Lewis $16.00 $13.10   22.14%
08/23/2021 Jefferies Jonathan Petersen $19.00 $15.35   23.78%
05/03/2021 Capital One Financial Daniel Bernstein $20.00 $16.43   21.73%

Sabra Healthcare REIT Inc FAQ's

Sabra Healthcare REIT Inc has been rated by research analysts at Mizuho Securities, Barclays, UBS, Robert W. Baird, Truist Financial, Scotiabank in the past 90 days.

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.